Merkel cell carcinoma: treatment and outcomes

Cancer. 2005 Oct 15;104(8):1761-4. doi: 10.1002/cncr.21355.

Abstract

Background: The purpose of the current study was to determine the outcomes of patients with previously untreated Merkel cell carcinoma of the skin who were treated with curative intent.

Methods: Between October 1984 and January 2002, 34 patients were treated with radiotherapy alone (2 patients) or combined with surgery (32 patients). Nine patients received adjuvant chemotherapy. Patients had follow-up for a median of 3.0 years (range, 0.3 to 18.5 yrs). Follow-up on living patients ranged from 2.2 to 18.5 years (median, 7.1 yrs).

Results: The 5-year outcomes were as follows: local control, 94%, locoregional control, 80%; freedom from distant metastases, 60%; cause-specific survival, 52%; and survival, 37%. No patient experienced a severe complication.

Conclusions: Patients treated aggressively with surgery and locoregional radiotherapy have about a 50% chance of cure. Limited data suggest that definitive radiotherapy alone or after incomplete macroscopic resection may control locoregional disease in a significant subset of patients. The dominant site of failure was distant.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Merkel Cell / drug therapy
  • Carcinoma, Merkel Cell / radiotherapy
  • Carcinoma, Merkel Cell / surgery
  • Carcinoma, Merkel Cell / therapy*
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / radiotherapy
  • Skin Neoplasms / surgery
  • Skin Neoplasms / therapy*
  • Survival Rate
  • Treatment Outcome

Substances

  • Antineoplastic Agents